Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB3 | P13945 | 19/20 | 0.65 |
| ▸ | ADRB1 | P08588 | 14/20 | 0.65 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | ADRB2 | P07550 | 8/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8477156 | 1.00 | ADRB3 (0.65) | ADRB3ADRB1ALOX15ADRB2 | |
| SCHEMBL8477150 | 1.00 | ADRB3 (0.65) | ADRB3ADRB1ALOX15ADRB2 | |
| SCHEMBL8427328 | 0.89 | ADRB3 (0.60) | ADRB3ADRB1ALOX15ADRB2 | |
| SCHEMBL8480316 | 0.88 | ADRB3 (0.61) | ADRB3ADRB1ALOX15ADRB2 | |
| SCHEMBL8480309 | 0.88 | ADRB3 (0.61) | ADRB3ADRB1ALOX15ADRB2 | |
| SCHEMBL8480311 | 0.88 | ADRB3 (0.61) | ADRB3ADRB1ALOX15ADRB2 | |
| SCHEMBL3704286 | 0.87 | ADRB3 (0.60) | ADRB3ADRB1ALOX15ADRB2 | |
| SCHEMBL3704284 | 0.87 | ADRB3 (0.60) | ADRB3ADRB1ALOX15ADRB2 | |
| SCHEMBL3511598 | 0.87 | ADRB3 (0.65) | ADRB3ADRB1ALOX15ADRB2 | |
| SCHEMBL3157183 | 0.87 | ADRB3 (0.65) | ADRB3ADRB1ALOX15ADRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1003744-A1 | 4-AMINOPYRROLE(3,2-d) PYRIMIDINES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS | Pfizer Products Inc. (US) | 2000-05-31 | — | — | EP | claimed |
| WO-1999007703-A1 | 4-AMINOPYRROLE(3,2-d) PYRIMIDINES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS | PFIZER PRODUCTS INC. (US) | 1999-02-18 | — | — | WO | claimed |
| US-5977124-A | β-adrenergic agonists | PFIZER INC. (US) | 1999-11-02 | — | — | US | disclosed |
| EP-0828712-A1 | BETA-ADRENERGIC AGONISTS | PFIZER INC. (US) | 1998-03-18 | — | — | EP | disclosed |
| EP-0824519-A1 | BETA-ADRENERGIC AGONISTS | PFIZER INC. (US) | 1998-02-25 | — | — | EP | disclosed |
| WO-1996035671-A1 | β-ADRENERGIC AGONISTS | PFIZER INC. (US) | 1996-11-14 | — | — | WO | disclosed |
| WO-1996035670-A1 | β-ADRENERGIC AGONISTS | PFIZER INC. (US) | 1996-11-14 | — | — | WO | disclosed |